News

Why Trump ordered ouster of FDA official
The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
FDA Ashanti regional head assures public of anonymity for reporting unsafe food sellers
Correspondence from the Ashanti Region Following a recent sensitization program at the Santasi Market as part of the World Food Safety Day, John Laryea Odai-Tettey, Ashanti Region ...
FDA Head To ‘Listen To Concerns’ Regarding Coerced Use Of Abortion Pill Widely Available Online
Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding ...
GlobalData on MSN6d
George Tidmarsh to sub in as FDA CBER head following Prasad’s shock exit
Tidmarsh will temporarily guide CBER’s regulatory activities while the FDA searches for a permanent department lead.
STAT7d
FDA names drug regulator Tidmarsh acting head of biologics center after Prasad’s exit
George Tidmarsh is taking on more responsibilities at FDA after the sudden departure of top official Vinay Prasad.
pharmaphorum8d
Vinay Prasad abruptly departs from the FDA
Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three ...
XBI: Surprise Exit Of A Tough Regulator At The FDA
The SPDR® S&P Biotech ETF rebounded over 20% since lows in April, despite changes at the FDA that could have signaled a ...
BioSpace7d
New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit
George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a ...
Sarepta, Replimmune, Capricor rise as FDA’s biologics head departs
Sarepta (NASDAQ:SRPT) stock, Replimune (NASDAQ:REPL) stock and Capricor (CAPR) stock surge as FDA's biologics head exits abruptly. Read more here.
Science-Based Medicine13dOpinion
With Laura Loomer on One Side and Dr. Paul Offit on the Other, Our FDA Leaders are Caught in a Trap of Their Own Making
After years of bashing the medical establishment, Drs. Vinay Prasad and Marty Makary are stuck in a trap. Any attempt to ...
Fierce Pharma7d
FDA taps newly appointed George Tidmarsh as acting CBER leader after Vinay Prasad exit
Freshly appointed Center for Drug Evaluation and Research (CDER) leader George Tidmarsh, M.D., Ph.D., will now take on the role of acting director of CBER as well, according to an internal letter from ...